Baldassarre Stea
Department of Radiation Oncology
Arizona Cancer Center
University of Arizona
1501 N. Campbell Ave
USA
Name/email consistency: high
- Whole-brain radiotherapy with or without efaproxiral for the treatment of brain metastases: Determinants of response and its prognostic value for subsequent survival. Stea, B., Suh, J.H., Boyd, A.P., Cagnoni, P.J., Shaw, E. Int. J. Radiat. Oncol. Biol. Phys. (2006)
- Efaproxiral red blood cell concentration predicts efficacy in patients with brain metastases. Stea, B., Shaw, E., Pintér, T., Hackman, J., Craig, M., May, J., Steffen, R.P., Suh, J.H. Br. J. Cancer (2006)
- Time and dose-dependent radiosensitization of the glioblastoma multiforme U251 cells by the EGF receptor tyrosine kinase inhibitor ZD1839 ('Iressa'). Stea, B., Falsey, R., Kislin, K., Patel, J., Glanzberg, H., Carey, S., Ambrad, A.A., Meuillet, E.J., Martinez, J.D. Cancer Lett. (2003)
The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.








